Vasoactive Intestinal Peptide Fragment 6-28

Description

Vasoactive Intestinal Peptide Fragment 6-28
Catalog number: B2013496
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.5 mg
Molecular Weight or Concentration: 2816.2 g/mol
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: VIP 6-28
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Summers MA, O’Dorisio MS, Cox MO, Lara-Marquez M, Goetzl EJ. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects J Pharmacol Exp Ther. 2003 Aug;306(2):638-45.
2: Schuelert N, McDougall JJ. Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis Osteoarthritis Cartilage. 2006 Nov;14(11):1155-62.
3: Mohney RP, Zigmond RE. Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury J Neurosci. 1998 Jul 15;18(14):5285-93.
4: Arcuni JC, Stoner MC, Kellum JM. Vasoactive intestinal peptide is a neuropeptide mediator of the secretory response to serotonin in rat J Surg Res. 2000 Jun 15;91(2):118-22.
5: Tams JW, Jorgensen RM, Holm A, Fahrenkrug J. Creation of a selective antagonist and agonist of the rat VPAC(1) receptor using a combinatorial approach with vasoactive intestinal peptide 6-23 as template Mol Pharmacol. 2000 Nov;58(5):1035-41.
6: Sághy É, Payrits M, Helyes Z, Reglődi D, Bánki E, Tóth G, Couvineau A, Szőke É. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons Neuroscience. 2015 Nov 12;308:144-56.
7: Ivanova M, Belcheva S, Belcheva I, Negrev N, Tashev R. Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression Psychopharmacology (Berl). 2012 Jun;221(4):561-74.
8: Saetrum Opgaard O, Knutsson M, de Vries R, Tom B, Saxena PR, Edvinsson L. Vasoactive intestinal peptide has a direct positive inotropic effect on isolated human myocardial trabeculae Clin Sci (Lond). 2001 Dec;101(6):637-43.
9: McDougall JJ, Watkins L, Li Z. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis Pain. 2006 Jul;123(1-2):98-105.
10: Gourlet P, Vandermeers A, Vandermeers-Piret MC, De Neef P, Robberecht P. Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy Int J Pept Protein Res. 1996 Oct;48(4):391-6.

Products Related to Vasoactive Intestinal Peptide Fragment 6-28 can be found at Peptides